Information Library

Results for: Europe - France

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • CBI 8th Annual Summit on Late Phase Research

    Event — Conference Date(s): February 28 - February 29, 2012
    Location: Amsterdam, the Netherlands

  • DIA Europe 2012

    Event — Conference Date(s): March 26 - March 28, 2012
    Location: Copenhagen, Denmark

  • ISPOR Europe 2012

    Event — Conference Date(s): November 3 - November 7, 2012
    Location: Berlin, German

  • The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio

    Hear from the Experts — December 6, 2011
    This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies.

  • Energizing Enrollment

    Case Study — October 4, 2011
    The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned.

  • Model-Based Drug Development

    Brochure — October 4, 2011
    Our industry-leading model-based drug development services boost the probability of success in the New Health by enabling you to make critical decisions earlier, optimizing your resources and returns.

  • Quintiles, Kadrige Open E-Solutions Operation in the US

    Press Release — August 2, 2011 – Quintiles and Kadrige, the market leader in e-detailing and multichannel sales solutions for the pharmaceutical and healthcare industries, today announced the opening of the first Kadrige office in the U.S.

  • Digital Pathology Central Laboratory Services Fact Sheet

    Brochure — June 23, 2011
    This fact sheet highlights Quintiles' digital pathology services, covering everything from scanning of slides to review and analysis - giving you a faster, easier way to scan and share this critical research data.

  • Genomics Fact Sheet

    Brochure — June 17, 2011
    Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area.

  • Scientific Bulletin Flow Cytometry

    Case Study — February 9, 2011
    Quintiles has expertise in running highly regulated flow cytometry assays, as well as a number of esoteric assays, such as multicolor cell surface and intracellular staining assays, and receptor occupancy/competitive binding assays.

Page 1 of 3 (28 results)

Subscribe to Email Based on Your Interests

Set preferences